Loomis Sayles & CO L P Dexcom Inc Transaction History

Loomis Sayles & CO L P

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $1,985 - $2,528	18 Added 2.96%	626 $71,000
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $15,077 - $18,493	132 Added 27.73%	608 $84,000
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $17,589 - $28,929	-233 Reduced 32.86%	476 $59,000
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $180,295 - $288,963	-2,095 Reduced 74.71%	709 $66,000
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $245,746 - $286,191	2,185 Added 352.99%	2,804 $360,000
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $207,272 - $244,979	-1,993 Reduced 76.3%	619 $72,000
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $123,645 - $178,484	-1,455 Reduced 35.78%	2,612 $296,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $263,789 - $325,391	3,455 Added 564.54%	4,067 $327,000
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $41,609 - $81,328	612 New	612 $46,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $2,667 - $3,579	-25 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $2,024 - $2,698	25 New	25 $11,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $5,002 - $6,179	-59 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $22,698 - $30,409	-291 Reduced 83.14%	59 $22,000
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $7,960 - $13,378	-127 Reduced 26.62%	350 $142,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $17,467 - $27,327	477 New	477 $104,000
Q3 2017 Nov 14, 2017	SELL	$11.36 - $18.98 $952,115 - $1.59 Million	-83,813 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	83,813	83,813 $6.13 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.